Skip to main content

Table 1 Clinical baseline characteristics

From: Influences of blood lipids on the occurrence and prognosis of hemorrhagic transformation after acute cerebral infarction: a case-control study of 732 patients

Characteristics Total (n = 732) Group A (n = 628) Group B (n = 104) P
Age, mean ± SD 66.17 ± 13.19 65.81 ± 13.14 68.34 ± 13.34 0.070
  < 50 78 (10.7) 69 (11.0) 9 (8.7) 0.697
 50–70 368 (50.3) 322 (51.3) 46 (44.2) 0.561
  > 70 286 (39.0) 237 (37.7) 49 (47.1) 0.661
Female/Male [n (%)]X 253/479 (34.6/65.4) 211/417 (33.6/66.4) 42/62 (40.4/59.6) 0.178
HBP, no/yes [n (%)] 218/514 (29.8/70.2) 190/438 (30.3/69.7) 28/76 (26.9/73.1) 0.491
DM, no/yes [n (%)]H 487/245 (66.5/33.5) 424/204 (67.5/32.5) 63/41 (60.6/39.4) 0.165
Hlip, no/yes [n (%)]H 584/148 (79.8/20.2) 496/132 (79.0/21.0) 88/16 (84.6/15.4) 0.185
AF, no/yes [n (%)]H 604/128 (82.5/17.5) 541/ 87 (86.1/13.9) 63/41 (60.6/39.4) < 0.001
SBP (mmHg) 150.35 ± 23.26 150.54 ± 23.45 149.20 ± 22.14 0.586
DBP (mmHg) 84.71 ± 13.49 84.83 ± 13.73 83.98 ± 12.00 0.550
NIHSS 7.05 ± 6.27 6.50 ± 6.10 10.39 ± 6.25 < 0.001
Hypoproteinemia, no/yes [n (%)]H 638/94 (87.2/12.8) 550/78 (87.6/12.4) 88/16(84.6/15.4) 0.403
Glucose (mmol/L) 7.33 ± 3.63 7.19 ± 3.57 8.16 ± 3.87 0.011
TC (mmol/L) 4.36 ± 1.05 4.39 ± 1.04 4.15 ± 1.08 0.035
  < 3.10 77 (10.5) 58 (9.3) 19 (18.3) 0.857
 3.10–5.70 578 (79.0) 507 (80.7) 71 (68.2) 0.047
  > 5.70 77 (10.5) 63 (10.0) 14 (13.5) 0.038
TG (mmol/L) 1.41 ± 0.87 1.44 ± 0.90 1.24 ± 0.70 0.030
  < 0.57 47 (6.4) 40 (6.4) 7 (6.7) 0.999
 0.57–1.7 514 (70.2) 435 (69.2) 79 (76.0) 0.044
  > 1.7 171 (23.4) 153 (24.4) 18 (17.3) 0.417
HDL-C (mmol/L) 1.16 ± 0.33 1.15 ± 0.33 1.21 ± 0.32 0.074
  < 0.83H 102 (13.9) 92 (14.6) 10 (9.6) 0.192
 0.83–1.96H 614 (83.9) 523 (83.3) 91 (87.5) 0.184
  > 1.96H 16 (2.2) 13 (2.1) 3 (2.9) 0.106
LDL-C (mmol/L) 2.83 ± 0.94 2.86 ± 0.92 2.67 ± 1.01 0.056
  < 2.07 152 (20.8) 124 (19.7) 28 (26.9) 0.001
 2.07–3.1 330 (45.0) 285 (45.4) 45 (43.3) 0.443
  > 3.1 250 (34.2) 219 (34.9) 31 (29.8) 0.761
  1. (X). P values were calculated by one-way ANOVA, Pearson’s Chi-square test; (H). P values were calculated by the Kruskal-Wallis H (H) test; HT Hemorrhagic transformation postacute cerebral infarction; HBP: History of hypertension; DM: Diabetes mellitus; Hlip Hyperlipidemia; SBP Systolic pressure; DBP Diastolic pressure; NIHSS National Institutes of Health Stroke Scale; TC Total cholesterol; TG Triglyceride; HDL-C High-density lipoprotein cholesterol; LDL-C Low-density lipoprotein cholesterol
\